Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

By LabMedica International staff writers
Posted on 18 Apr 2025

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. More...

They are also integral in forensic investigations and biosensing. Fluorophores have been utilized by scientists to highlight cells and tissues under specialized microscopes, making even the smallest details visible. These molecules also play a crucial role in tracking diseases, studying cellular functions, and assisting in the diagnosis of various health conditions. Now, researchers have developed tiny, clay-based materials known as fluorescent polyionic nanoclays, which can be tailored for numerous applications, including improving medical tests.

These fluorescently labeled nanoclays, created by researchers at the University of Missouri-Columbia (Columbia, MO, USA), exhibit an exceptional brightness of 7,000 brightness units when normalized by volume, marking the highest levels ever recorded for a fluorescent material. This increased brightness makes these materials highly effective for sensitive optical detection methods, leading to stronger analytical signals and improved detection. These enhancements open up new possibilities for advanced sensors and contrast agents in medical imaging. Published in Chemistry of Materials, the study emphasizes the versatility of these nanoclays, which can be adapted to a variety of applications. They have a high degree of functionality, allowing for precise control over the number and type of fluorescent molecules attached to their surfaces. This capability provides a flexible platform where the optical and physicochemical properties of the nanoclays can be finely tuned by selecting and attaching specific molecules.

One of the key features of these nanoclays is their ability to be easily customized, making them suitable for diverse applications in different fields. Initial tests suggest that these materials are safe for medical use, potentially enabling doctors to see inside the body with greater clarity. Although fluorescence remains the primary focus of current research, the team plans to further explore the customization of these nanoclays by incorporating other molecules, such as amino acids, antibodies, DNA aptamers, and ligands for selective metal binding. This opens up opportunities for applications beyond just imaging and sensing. These materials could also play a significant role in drug delivery, improving medical tests, monitoring diseases, and aiding in cancer treatment.


Gold Member
Automated MALDI-TOF MS System
EXS 3000
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
ESR Analyzer
TEST1 2.0
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Research has linked platelet aggregation in midlife blood samples to early brain markers of Alzheimer’s (Photo courtesy of Shutterstock)

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more

Microbiology

view channel
Image: Development of targeted therapeutics and diagnostics for extrapulmonary tuberculosis at University Hospital Cologne (Photo courtesy of Michael Wodak/Uniklinik Köln)

Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis

Extrapulmonary tuberculosis (EPTB) remains difficult to diagnose and treat because it spreads beyond the lungs and lacks easily accessible biomarkers. Despite TB infecting 10 million people yearly, the... Read more

Pathology

view channel
Image: The AI tool combines patient data and images to detect melanoma (Photo courtesy of Professor Gwangill Jeon/Incheon National University)

AI Tool to Transform Skin Cancer Detection with Near-Perfect Accuracy

Melanoma continues to be one of the most difficult skin cancers to diagnose because it often resembles harmless moles or benign lesions. Traditional AI tools depend heavily on dermoscopic images alone,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.